FICO vs MSFT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FICO demonstrates elite profitability and consistent earnings outperformance, supported by strong double-digit revenue and earnings growth, positioning it favorably within the high-margin software application sector. Despite a 25% pullback over the past year, the stock shows signs of stabilization with a 6.4% rebound in the last six months and positive near-term momentum. Valuation remains rich but justifiable given superior margins—particularly the 48.1% operating margin and 82.2% gross margin—relative to peers trading at higher multiples despite weaker fundamentals. Analysts reflect confidence with a $2016 target implying 15.7% upside, though insider selling activity presents a notable counter-signal.
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
Compare Another Pair
Related Comparisons
FICO vs MSFT: Head-to-Head Comparison
This page compares Fair Isaac Corporation (FICO) and Microsoft Corporation (MSFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.